[Form 4] CalciMedica, Inc. Insider Trading Activity
Rhea-AI Filing Summary
CalciMedica, Inc. reported that Eric W. Roberts, its chief business officer, director, and a ten percent owner, made an open-market purchase of common stock. On September 15, 2025, a Roth IRA account for his benefit bought 3,400 shares at a weighted average price of $2.6779 per share, with trade prices ranging from $2.65 to $2.70. Following this transaction, that Roth IRA held 81,650 common shares. The filing also updates his other direct and indirect common stock positions, including shares held directly and through multiple IRA and Valence Investments SPV entities.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 3,400 shares
Net Buy
7 txns
Insider
Roberts Eric W
Role
CHIEF BUSINESS OFFICER
Bought
3,400 shs ($9K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 3,400 | $2.6779 | $9K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 81,650 shares (Indirect, By FMTC Custodian - Roth IRA FBO Eric W. Roberts);
Common Stock — 179,706 shares (Direct);
Common Stock — 49,894 shares (Indirect, By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA);
Common Stock — 10,661 shares (Indirect, By IRA Financial Trust Company CFBO Eric W. Roberts);
Common Stock — 356,989 shares (Indirect, By Valence Investments SPV IV, LLC);
Common Stock — 66,228 shares (Indirect, By Valence Investments SPV V, LLC);
Common Stock — 316,109 shares (Indirect, By Valence Investments SPV VI, LLC)
Footnotes (1)
- F1. The weighted average purchase price for the transaction reported was $2.6779, and the range of prices were between $2.65 and $2.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
AI-generated analysis. How Rhea-AI works. Not financial advice.
